Licensing PDRN Oral Supplement
Empower your brand with clinically validated biotechnology. Polymor Biotech offers exclusive licensing for our proprietary PDRN polynucleotide oral delivery complexes, engineered for maximum efficacy and pharmaceutical precision. Designed for established global brands seeking a defensible scientific edge.
Partnership Models
Exclusive Territory
Secure sole commercial rights for Polymor oral delivery complexes within defined geographic regions, ensuring market leadership and competitive insulation.
Indication-Specific
License our high-precision technology for specific therapeutic categories or clinical indications, allowing for targeted product development pipelines.
Co-Branded Integration
Licensing partners may reference the Polymor Biotech name and active patent filing in product communications, subject to agreed brand guidelines.
01
1. Initial enquiry
Official communication to propose collaboration and express interest in our oral delivery biotechnology.
Licensing Process
02
2. Mutual NDA execution
Formalizing confidentiality protocols between Polymor Biotech and your firm to protect proprietary data.
03
3. Full dossier issued for requested complex
Transmission of comprehensive clinical documentation and technical specifications for the selected complex.
04
4. Term sheet negotiation
Finalizing the financial and operational framework for the commercial use of our delivery systems.